Tristel Plc provided earnings guidance for the six months ended December 31, 2012. The management now expects a much lower level of endoscopy revenues in this financial year. This will result in an adjusted pre-tax loss for the six months to 31 December 2012 of approximately £0.6 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
420 GBX | +0.60% | -1.75% | -8.70% |
May. 08 | Tristel plc Announces the Publication of A White Paper Simplifying High-Level Disinfection for Urological Procedures | CI |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.70% | 254M | |
+11.46% | 8.66B | |
+43.15% | 2.6B | |
-18.01% | 987M | |
+17.21% | 857M | |
-13.89% | 752M | |
+28.49% | 718M | |
+17.83% | 694M | |
-19.45% | 583M | |
+6.83% | 541M |
- Stock Market
- Equities
- TSTL Stock
- News Tristel plc
- Tristel Plc Provides Earnings Guidance for the Six Months Ended December 31, 2012